Fig. 3From: Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis(A) The pooled incidence rate of any-grade flares; (B) The pooled incidence rate of any-grade flares after excluding the studies from AustraliaBack to article page